title: Re: intrathecal vincristine as mentioned in 'overview of recent trends in diagnosis and management of leptomeningeal multiple myeloma' by Yellu et al.
authors.affiliation: Department of Medicine, Duke University Medical Center, Durham, NC, USA.
authors.forename: Li-Wen
authors.initials: LW
authors.lastname: Huang
authors.affiliation: Division of Hematologic Malignancies and Cellular Therapy, Duke Cancer Institute, Durham, NC, USA.
authors.forename: Sascha A
authors.initials: SA
authors.lastname: Tuchman
mesh_terms: D005260:Female; D006801:Humans; D007278:Injections, Spinal; D008297:Male; D008577:Meningeal Neoplasms / Q000188:drug therapy*; D009101:Multiple Myeloma / Q000188:drug therapy*; D014750:Vincristine / Q000008:administration & dosage*
chemical_list: D014750:Vincristine